Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Top Cited Papers
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 13 (2), 89-92
- https://doi.org/10.1016/j.parkreldis.2006.12.001
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Frequency of LRRK2 mutations in early- and late-onset Parkinson diseaseNeurology, 2006
- Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of dataThe Lancet Neurology, 2006
- LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia AgoAmerican Journal of Human Genetics, 2006
- Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S MutationsArchives of Neurology, 2006
- LRRK2 in Parkinson's disease: protein domains and functional insightsTrends in Neurosciences, 2006
- Genetics of Parkinson disease: paradigm shifts and future prospectsNature Reviews Genetics, 2006
- LRRK2G2019S as a Cause of Parkinson's Disease in North African ArabsNew England Journal of Medicine, 2006
- LRRK2G2019S as a Cause of Parkinson's Disease in Ashkenazi JewsNew England Journal of Medicine, 2006
- High-Resolution Whole-Genome Association Study of Parkinson DiseaseAmerican Journal of Human Genetics, 2005
- Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European PopulationsAmerican Journal of Human Genetics, 2005